Patent application number | Description | Published |
20100209601 | METHOD OF MANUFACTURING A MAGNETIC DISK - On manufacturing a magnetic disk having at least a magnetic layer ( | 08-19-2010 |
20100246064 | LUBRICANT COMPOUND FOR A MAGNETIC DISK, MAGNETIC DISK, AND METHOD OF MANUFACTURING THE SAME - In a magnetic disk has at least a magnetic layer, a carbon-based protective layer, and a lubricating layer formed in this order over a substrate, the lubricating layer contains a lubricant compound including a compound which has a perfluoropolyether main chain in a structure thereof, an aromatic group located at a position except each end of a molecule thereof, and a polar group at each end of the molecule. | 09-30-2010 |
20120127601 | LUBRICANT COMPOUND FOR MAGNETIC DISK AND MAGNETIC DISK - A lubricant compound for a magnetic disk is provided which can realize further reduction of the magnetic spacing and moreover, has high reliability under a lower floating amount of the magnetic head involved with the recent rapid increase in the recording density and under extremely severe environmental resistance involved with diversification of the applications. | 05-24-2012 |
20120148875 | LUBRICANT FOR MAGNETIC DISC, MAGNETIC DISC AND METHOD OF PRODUCING THE SAME - A magnetic disk with which further reduction of magnetic spacing can be realized and which has high reliability under such circumstances of a lower floating amount of a magnetic head involved in the recent rapid increase in recording density and of extremely severe environmental resistance involved in diversification in use applications is provided. | 06-14-2012 |
20120225217 | METHOD OF PRODUCING A MAGNETIC RECORDING DISC - A method of manufacturing a magnetic disk in which at least a magnetic layer, a carbon protective layer, and a lubrication layer are sequentially formed on a substrate is provided. The method comprises forming a film of a lubricant composition on the protective layer, the lubricant comprising a lubricant compound having a perfluoropolyether main chain in the molecular structure and an aromatic group or a phosphazene ring. The method further comprises forming the lubrication layer, and subjecting the magnetic disk to ultraviolet irradiation under a nitrogen gas or an inert gas atmosphere having an oxygen concentration of 5 volume % or less by adjusting an atmospheric temperature to a range of 50 to 180° C. | 09-06-2012 |
20120276417 | LUBRICANT FOR MAGNETIC DISK AND MAGNETIC DISK - A lubricant for a magnetic disk that is excellent in heat resistance and is suitably used in a magnetic disk to be mounted on a magnetic recording device of a thermally assisted magnetic recording system and a magnetic disk provided with a lubricant layer containing this lubricant. The lubricant for a magnetic disk contains a compound where perfluoropolyether groups each having a perfluoropolyether main chain in its structure and a phosphazene ring at an end are linked to each other through a linking group. The linking group is an aliphatic group or a phosphazene ring. In a magnetic disk having at least a magnetic recording layer, a protective layer, and a lubricant layer on a substrate, the lubricant layer contains the lubricant for a magnetic disk. | 11-01-2012 |
20130194664 | POLARIZING LENS - An aspect of the present invention relates to a polarizing lens, which comprises a polarizing layer comprising a dichroic dye and a functional film in this order on a lens substrate, and further comprises a waterborne resin layer between the polarizing layer and the functional film as a layer adjacent to both the polarizing layer and functional film, wherein the waterborne resin layer is greater than 0.50 μm in thickness and has been formed by coating and drying a waterborne resin composition comprising a polyether polyurethane resin and a water-based solvent. | 08-01-2013 |
20130196077 | METHOD OF MANUFACTURING POLARIZING LENS - An aspect of the present invention relates to a method of manufacturing a polarizing lens, which comprises forming a polarizing layer by orienting and depositing a dichroic dye on a lens substrate; conducting an amino silane treatment by impregnating the polarizing layer with a solution of a silane coupling agent comprising an amino group; coating a waterborne resin composition comprising a polyether polyurethane resin and a water-based solvent on the polarizing layer following the amino silane treatment and then drying the waterborne resin composition to form a primer layer; and forming a cured coating by coating a curable composition on the primer layer that has been formed and then conducting a curing treatment. | 08-01-2013 |
Patent application number | Description | Published |
20090092544 | Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody - It is an object of the present invention to provide a novel antibody capable of specifically recognizing ROBO1 that is expressed in a cell membrane, a hybridoma that produces the above antibody, a method for producing the above antibody, and a tumor diagnostic agent used in PET comprising the above antibody. The present invention provides a monoclonal antibody capable of specifically recognizing ROBO1 existing on the surface of a cell, which is obtained by immunizing an animal to be immunized with a ROBO1-displaying budded baculovirus recovered from the culture supernatant of host cells infected with a recombinant baculovirus comprising the full-length cDNA of ROBO1 as an antigen. | 04-09-2009 |
20100041167 | DRUG FOR DIAGNOSING LARGE INTESTINAL CANCER AND/OR POLYP, OBSERVING POSTOPERATIVE COURSE AND MONITORING RECURRENCE - The present invention is directed to a method for diagnosing large intestinal cancer and/or polyp and a method for observing postoperative course or monitoring recurrence thereof, wherein each method includes detecting cystatin SN protein by use of an anti-cystatin SN antibody. The present invention is able to provide a kit for assaying cystatin SN, which can be used, in a simple manner, in a diagnosis performed prior to conventional barium enema examination and endoscopic examination which impose burdens on patients; as an indicator of metastasis and recurrence; and in the evaluation of therapeutic effects. The present invention provides a method for diagnosing or monitoring large intestinal cancer and/or polyp which can be performed in a simple manner, and thus can allow to design a new regimen rapidly. | 02-18-2010 |
20100062449 | Method Of Measuring PTX3 With High Sensitivity - To provide a method of determining vasculopathy, which is a risk factor of myocardial infarction, angiopathic dementia, etc., at an early stage thereof (i.e., mild vasculopathy). The present invention provides a method of determining the severity of mild vasculopathy, including determining PTX3 level in an assay sample by use of an anti-PTX3 monoclonal antibody. | 03-11-2010 |
20100093010 | Inhibitor for the Formation of Gamma-Secretase Complex - It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells. | 04-15-2010 |
20100221766 | NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME - A nuclear transfer promoter for Cdc42 protein comprising an isoprenoid synthesis inhibitor and/or a geranylgeranyl transferase inhibitor such as an HMG-CoA synthase inhibitor, an HMG-CoA reductase inhibitor, an AMPK activator or a farnesyl pyrophosphoric acid synthase preparation; utilization thereof; a method therefor; a blood vessel remedy comprising the nuclear transfer promoter for Cdc42 protein as the active ingredient; and a method of screening a blood vessel remedy which comprises assaying the ability of Cdc42 protein to transfer into nucleus. | 09-02-2010 |
20100247539 | Antibodies that Inhibit Transport Activity of Peptide Transporters - The present inventors discovered that the PepT-binding antibodies have the ability to inhibit the transport activity of peptide transporters, as a result of dedicated research. These antibodies may be utilized as cell growth inhibitors, for example, for treating and preventing cancer. | 09-30-2010 |
20120003149 | NOVEL MONOCLONAL ANTIBODY, AND USE THEREOF - [Theme] To provide a monoclonal antibody against human GPR87. Also, to provide a novel means for diagnosing or treating a malignant tumor. | 01-05-2012 |
20120039879 | STREPTAVIDIN HAVING LOW IMMUNOGENICITY AND USE THEREOF - It is an object of the present invention to provide a mutant streptavidin wherein the immunogenicity (antigenicity) in mammals of a streptavidin is reduced. The present invention provides a mutant streptavidin, which comprises an amino acid sequence in which (a) the arginine residue at position 72 is substituted with another amino acid residue, and (b) any one or more of the tyrosine residue at position 10, the tyrosine residue at position 71, the glutamic acid residue at position 89, the arginine residue at position 91, and the glutamic acid residue at position 104 are substituted with other amino acid residues, with respect to the amino acid sequence of a core streptavidin as shown in SEQ ID NO: 2, and which has decreased immunogenicity as compared with that of a wild-type streptavidin. | 02-16-2012 |
20140322726 | MONOCLONAL ANTIBODY SPECIFICALLY RECOGNIZING ASPARAGINE SYNTHETASE - It is an object of the present invention to provide a monoclonal antibody, which is suitable for the quantitative analysis of asparagine synthetase in a cell. The present invention provides a monoclonal antibody which specifically recognizes asparagine synthetase that is present in a cell. | 10-30-2014 |